drugset / Trial / NCT01690338

Summary

The purpose of this study is to determine the incidence of residual curarization in PACU and relevant risk factors.

Timeline

Start
2012-10
Primary completion
2014-10
Completion
2014-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cisatracurium Small molecule
Comparator Rocuronium Other / unclassified
Comparator Vecuronium Small molecule